APOE and amyloidosis: Numerous studies have suggested that APOE genotype is associated with amyloid angiopathy in sporadic CSVD, and biomarkers suggesting BBB damage, such as inflammatory factors and coagulation factors, are closely related to non-amyloidosis subtypes, especially their close association with neuroimaging markers.